The US Food and Drug Administration (FDA) has announced its plans to address the recommendations put forward in December in a damning report by the Reagan-Udall Foundation on the performance of its Center for Tobacco Products (CTP).

CTP director Brian King said the centre was “committed to addressing all the recommendations outlined in the report as expeditiously as possible”, although the implementation of some of them would require time and external collaboration.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us